Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06BCB
|
||||
Former ID |
DAP001437
|
||||
Drug Name |
Vinpocetine
|
||||
Synonyms |
Bravinton; Cavinton; Ceractin; Vinpocetinum; Apovincaminic acid ethyl ester; AY 27255; RGH 4405; TCV 3B; V 6383; V6383_SIGMA; AY 27,255; Apovincaminate d'ethyle; Apovincaminate d'ethyle [French]; Cavinton (TN); Cis-Apovincaminic acid ethyl ester; Intelectol (TN); RGH-4405; TCV-3B; Ultra-Vinca; Vinpocetine-ethyl apovincaminate; Vinpocetinum [INN-Latin]; Eburnamenine-14-carboxylic acid ethyl ester; Ethyl apovincamin-22-oate; Vinpocetine [USAN:INN:JAN]; Ethyl (+)-apovincaminate; Vinpocetine (JAN/USAN/INN); Ethyl(+)-cis-apovincaminate; Ethyl apovincaminate, (3alpha,16alpha)-isomer; Ethyl (3alpha,16alpha)-eburnamenine-14-carboxylate; (+)-Apovincaminic acid ethyl ester; (+)-cis-Apovincaminic acid ethyl ester; (3alpha, 16alpha)-Eburnamenine-14-carboxylic acid ethyl ester; 1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine, eburnamenine-14-carboxylic acid deriv.; 3-alpha,16-alpha-Apovincaminic acid ethyl ester
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Vasodilator Agents
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H26N2O2
|
||||
InChI |
InChI=1S/C22H26N2O2/c1-3-22-11-7-12-23-13-10-16-15-8-5-6-9-17(15)24(19(16)20(22)23)18(14-22)21(25)26-4-2/h5-6,8-9,14,20H,3-4,7,10-13H2,1-2H3/t20-,22+/m1/s1
|
||||
InChIKey |
DDNCQMVWWZOMLN-IRLDBZIGSA-N
|
||||
CAS Number |
CAS 42971-09-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
855619, 3727081, 7848434, 7980299, 10299443, 10321872, 11341598, 11361781, 11364294, 11366856, 11369418, 11371881, 11374568, 11377580, 11466296, 11467416, 11485054, 11486071, 11487183, 11489345, 11490776, 11492889, 11495214, 14802886, 14925387, 17405811, 24278182, 26612408, 26680355, 26759739, 36887098, 47216903, 47365339, 47440398, 47810892, 47959906, 48334637, 48334638, 48416699, 48483328, 49698412, 49964760, 50103960, 50103961, 50103962, 50103963, 50113284, 53778363, 53790458, 56424092
|
||||
SuperDrug ATC ID |
N06BX18
|
||||
SuperDrug CAS ID |
cas=042971095
|
||||
Target and Pathway | |||||
Target(s) | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1 | Target Info | Inhibitor | [537150] | |
References | |||||
Ref 537150 | Effects of phosphodiesterase inhibitors on contraction induced by endothelin-1 of isolated human prostatic tissue. Urology. 2009 Jun;73(6):1397-401. Epub 2009 Mar 13. | ||||
Ref 540748 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5285). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.